Ironwood Pharmaceuticals 10K 2012 Annual report | IRWD Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: adapt, adjudication, assembled, AstraZeneca, avoid, BESP, bottling, boxed, breast, broaden, capsule, cautioned, channel, China, chose, CIC, cohesive, compliant, constantly, Constella, contraindicated, correlated, CTA, database, deliverable, deployed, depth, developmental, dialogue, digital, disadvantage, distension, divest, epithelium, EU, evacuation, excellence, exploit, factor, flatulence, freedom, freight, FTE, geographic, GmbH, idiopathic, IDP, improper, improperly, incomplete, incorrectly, indenture, insignificant, installation, instructed, inter, inventory, ion, JDC, juvenile, licensee, luminal, Macau, men, mice, middle, milk, misuse, mouse, multinational, neonatal, nontransferable, Notwithstanding, OPDP, optimum, outlook, pharmacovigilance, placement, post, precluded, prompt, ratio, reformulation, region, repay, representation, residual, rightfully, rigorously, robust, SAB, saleable, secretory, sellable, send, shape, shelf, shipment, shortfall, stipulated, sublicense, sublicensed, symptomatic, synthetic, TPE, transforming, trustee, truthful, undermining, undistributed, unprofitable, upfront, upheld, USPTO, version, VSOE, waiver, wholesaler, wider

Removed: absenteeism, accompanied, activate, acutely, add, addressing, adherence, adherent, adjust, afferent, aim, Alimentary, alosetron, ambulatory, American, analogue, announced, applying, article, assure, Bent, billion, block, broader, Camilleri, carry, CC, Certified, cisapride, Cl, clinically, commented, commonly, community, compare, compensated, consistently, consulted, continuum, crucial, cytosol, decreasing, defecation, define, deleted, deny, desirable, detectable, disagree, disrupted, educated, EITF, electrolyte, employ, epithelial, Everhart, existed, exit, experiencing, extending, fact, firing, Foundation, generalist, genetically, GERD, GII, guideline, gut, halt, heartburn, Hepatology, Housing, hypersensitivity, hypothesize, IBS, IFFGD, illustrate, impaired, Importantly, inaccurate, inClinical, indirect, infrequency, inhibited, inhibiting, inhibitor, inQuality, inside, intestine, jeopardized, kinase, lansoprazole, largely, light, line, locally, Lotronex, Luscombe, medication, messenger, mild, Na, naturally, nonrecurring, obligation, observed, omeprazole, oral, outlining, overwhelming, painful, pantoprazole, peak, perspective, phosphorylation, physiological, PKGII, poorly, positioned, preclinical, preclinically, predominant, premium, preparing, Prevacid, Propulsid, protein, proton, Protonix, pump, recurrence, recurrent, reflux, refundable, regimen, reinforce, remeasurement, reportedly, repurchased, revise, sabbatical, secondary, sensation, setback, signaling, sodium, speak, spent, stable, stimulate, stimuli, straining, strict, Subtopic, sufferer, supplemental, symptom, systemic, Therapeuticsand, thrive, titled, tracked, tract, traditionally, treatable, turnover, understood, unduly, unique, unrelated, variable, vendor, viewed, water

Ironwood Pharmaceuticals (IRWD) 10-K2012 FY Annual report

Content analysis